Multiple myeloma and cardiovascular risk (a literature review)
Multiple myeloma is a plasma cell clonal malignancy that accounts for 10 % of hematological cancers. It predominantly affects elderly people; median age at diagnosis is 70 years. Consequently, many patients with MM have cardiovascular comorbidities or risk factors. MM can cause cardiac comorbidities...
Saved in:
| Main Authors: | B. B. Samura, M. O. Panasenko, S. Ya. Dotsenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2020-11-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/216234/216815 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiovascular events after polychemotherapy of multiple myeloma: modern ways to diagnostics
by: B. B. Samura, et al.
Published: (2020-03-01) -
Value of P-selectin in the prognosis of cardiovascular events in patients with multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-08-01) -
Circulating sST2 and prognosis of cardiovascular events in remission of multiple myeloma
by: M. O. Panasenko, et al.
Published: (2022-10-01) -
Chronic lymphoproliferative diseases and cardiovascular risk (a literature review)
by: B. B. Samura, et al.
Published: (2022-11-01) -
Circulating VE-catherin and prognosis of cardiovascular events in remission of multiple myeloma
by: B. B. Samura
Published: (2016-06-01)